nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
|
Teisseyre, Maxime |
|
|
6 |
4 |
p. 1183-1188 |
artikel |
2 |
A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD
|
Metzger, Maureen |
|
|
6 |
4 |
p. 894-904 |
artikel |
3 |
A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy
|
Hoxha, Elion |
|
|
6 |
4 |
p. 928-935 |
artikel |
4 |
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
|
Roccatello, Dario |
|
|
6 |
4 |
p. 1081-1087 |
artikel |
5 |
Association of Local Unit Sampling and Microbiology Laboratory Culture Practices With the Ability to Identify Causative Pathogens in Peritoneal Dialysis-Associated Peritonitis in Thailand
|
Kanjanabuch, Talerngsak |
|
|
6 |
4 |
p. 1118-1129 |
artikel |
6 |
Author Reply to Comment on “Assessment of Plasma Oxalate Concentration in Patients With CKD” by Oka et al.
|
Pfau, Anja |
|
|
6 |
4 |
p. 1194-1195 |
artikel |
7 |
Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events
|
Isik, Busra |
|
|
6 |
4 |
p. 1022-1031 |
artikel |
8 |
Blood Transfusion and Adverse Graft-related Events in Kidney Transplant Patients
|
Massicotte-Azarniouch, David |
|
|
6 |
4 |
p. 1041-1049 |
artikel |
9 |
C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question
|
Werion, Alexis |
|
|
6 |
4 |
p. 878-880 |
artikel |
10 |
Congenital Anomalies of the Kidney and Urinary Tract and Adulthood risk of Urinary Tract Cancer
|
Calderon-Margalit, Ronit |
|
|
6 |
4 |
p. 946-952 |
artikel |
11 |
Coronavirus Disease 2019 and Acute Kidney Injury: What Have We Learned?
|
Husain-Syed, Faeq |
|
|
6 |
4 |
p. 872-874 |
artikel |
12 |
Coronavirus Disease 2019 in Patients With End-Stage Kidney Disease on Hemodialysis in Guatemala
|
Sosa, Regina |
|
|
6 |
4 |
p. 1110-1117 |
artikel |
13 |
COVID-19–Associated Graft Loss From Renal Infarction in a Kidney Transplant Recipient
|
Webb, Christine |
|
|
6 |
4 |
p. 1166-1169 |
artikel |
14 |
COVID-19 Vaccination Acceptance and Hesitancy in Dialysis Staff: First Results From New York City
|
Pamplona, Gemma M. |
|
|
6 |
4 |
p. 1192-1193 |
artikel |
15 |
Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19
|
Hardenberg, Jan-Hendrik B. |
|
|
6 |
4 |
p. 905-915 |
artikel |
16 |
Decreasing Incidence of Acute Kidney Injury in Patients with COVID-19 Critical Illness in New York City
|
Charytan, David M. |
|
|
6 |
4 |
p. 916-927 |
artikel |
17 |
Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction
|
Kudose, Satoru |
|
|
6 |
4 |
p. 936-945 |
artikel |
18 |
Early Posttransplant Blood Transfusion and Risk for Worse Graft Outcomes
|
Daloul, Reem |
|
|
6 |
4 |
p. 986-994 |
artikel |
19 |
Eosinophilia Due to Central Venous Catheter in Hemodialysis Patients
|
Chapelet-Debout, Agnès |
|
|
6 |
4 |
p. 1189-1191 |
artikel |
20 |
Erratum to “Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis – Subgroup Analyses of the CALIPSO Trial.” Kidney Int. Rep. 2020;5:2178–2182
|
|
|
|
6 |
4 |
p. 1196 |
artikel |
21 |
Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes
|
Timmermans, Sjoerd A.M.E.G. |
|
|
6 |
4 |
p. 1099-1109 |
artikel |
22 |
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
|
Ariceta, Gema |
|
|
6 |
4 |
p. 1088-1098 |
artikel |
23 |
Hurts So Good: Uncovering the Relationship Between Blood Transfusions and Allograft Outcome
|
Sullivan, Harold C. |
|
|
6 |
4 |
p. 875-877 |
artikel |
24 |
Immune-Complex Glomerulonephritis After COVID-19 Infection
|
Sethi, Sanjeev |
|
|
6 |
4 |
p. 1170-1173 |
artikel |
25 |
Incidence and Temporal Trend in Risk Factors of Severe Infections in ANCA-Glomerulonephritis Patients
|
Jourdain, Pierre |
|
|
6 |
4 |
p. 1161-1165 |
artikel |
26 |
Living Organ Donor Health Care Priorities During the COVID-19 Pandemic
|
Zaidi, Hasan |
|
|
6 |
4 |
p. 1151-1155 |
artikel |
27 |
Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
|
Ashoor, Isa F. |
|
|
6 |
4 |
p. 995-1002 |
artikel |
28 |
Natural Killer Cell Large Granular Lymphocyte Leukemia-Induced Glomerulonephritis
|
Isnard, Pierre |
|
|
6 |
4 |
p. 1174-1177 |
artikel |
29 |
N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
|
Sasaki, Takaya |
|
|
6 |
4 |
p. 976-985 |
artikel |
30 |
Paraneoplastic REG1α Cast Nephropathy Associated With Mixed Acinar-Neuroendocrine Carcinoma
|
Nasr, Samih H. |
|
|
6 |
4 |
p. 1178-1182 |
artikel |
31 |
Performance and Determinants of Serum Creatinine and Cystatin C–Based GFR Estimating Equations in South Asians
|
Wang, Yeli |
|
|
6 |
4 |
p. 962-975 |
artikel |
32 |
Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD
|
Mallett, Andrew J. |
|
|
6 |
4 |
p. 1032-1040 |
artikel |
33 |
Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration
|
Chung, Erin |
|
|
6 |
4 |
p. 1003-1014 |
artikel |
34 |
Plasma Oxalate Concentration and Patients With CKD
|
Oka, Yoshinari |
|
|
6 |
4 |
p. 1194 |
artikel |
35 |
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease
|
El Ters, Mireille |
|
|
6 |
4 |
p. 953-961 |
artikel |
36 |
Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis
|
Nataatmadja, Melissa |
|
|
6 |
4 |
p. 1058-1065 |
artikel |
37 |
Renin-Angiotensin-Aldosterone System Inhibition and Mineralocorticoid Receptor Antagonists: The Overriding Importance of Enablers and Dampers
|
Epstein, Murray |
|
|
6 |
4 |
p. 869-871 |
artikel |
38 |
Risk for Significant Kidney Function Decline After Acute Kidney Injury in Adults With Hematologic Malignancy
|
May, Heather P. |
|
|
6 |
4 |
p. 1050-1057 |
artikel |
39 |
Rituximab in Membranous Nephropathy
|
Gauckler, Philipp |
|
|
6 |
4 |
p. 881-893 |
artikel |
40 |
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies
|
Gouin, Anna |
|
|
6 |
4 |
p. 1015-1021 |
artikel |
41 |
Survey of Current Practices of Outpatient Hemodialysis for AKI Patients
|
Ortiz-Soriano, Victor |
|
|
6 |
4 |
p. 1156-1160 |
artikel |
42 |
Temporal Trends in Hemoglobin, Use of Erythropoiesis Stimulating Agents, and Major Clinical Outcomes in Incident Dialysis Patients in Canada
|
Canney, Mark |
|
|
6 |
4 |
p. 1130-1140 |
artikel |
43 |
Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
|
Wetmore, James B. |
|
|
6 |
4 |
p. 1141-1150 |
artikel |
44 |
The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort
|
Palmer, Matthew B. |
|
|
6 |
4 |
p. 1066-1080 |
artikel |